Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Android iOS
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Search results for:

pregabalin

pregabalin
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Lyrica CR CAPSULE, EXTENDED RELEASE, ORAL 82.5 mg, 165 mg, 330 mg    
Lyrica CAPSULE, ORAL 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 300 mg      
Lyrica LIQUID, ORAL 20 mg/mL      
VIEW MORE Anticonvulsants, Miscellaneous
Comments:

Lyrica Medication Guide

Lyrica CR Medication Guide

Ordered Formulation Therapeutic Interchange
pregabalin (Lyrica CR)
  • 82.5 mg daily*
  • 165 mg daily
  • 247.5 mg daily
  • 330 mg daily
  • 495 mg daily
  • 660 mg daily
 pregabalin (Lyrica)
  • 25 mg TID*
  • 75 mg BID
  • 75 mg TID
  • 150 mg BID
  • 150 mg TID
  • 300 mg BID

Lyrica CR is non-formulary, not stocked. Automatic interchange to IR pregabalin.

Reviewed: 22 May 2018 (Lyrica CR)

Last updated: Dec. 6, 2019






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved